Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-08

Clinical Trial Update: Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating drug treatment plus risk reduction counseling to prevent HIV infection and death among injection drug users; study terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Opioid-Related Disorders | Phase 3 | Status: TERMINATED | Results posted: 2016-12-08